State-wise alcohol consumption per capita per week in India [7].
\r\n\t
",isbn:"978-1-83969-452-3",printIsbn:"978-1-83969-451-6",pdfIsbn:"978-1-83969-453-0",doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!0,hash:"a6e1a11c05ff8853c529750ddfac6c11",bookSignature:"Dr. René Mauricio Barría",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/10734.jpg",keywords:"Neonatal Intensive Unit, Neonatal Diagnostic Techniques, Neonatal Nurses, Neonatologists, Newborn Diseases, Premature Diseases, Breast Feeding, Kangaroo-Mother Care Method, Neonatal Survival, Limit of Viability, Minimal Handling, Neonatal Stress",numberOfDownloads:null,numberOfWosCitations:0,numberOfCrossrefCitations:null,numberOfDimensionsCitations:null,numberOfTotalCitations:null,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"February 5th 2021",dateEndSecondStepPublish:"March 5th 2021",dateEndThirdStepPublish:"May 4th 2021",dateEndFourthStepPublish:"July 23rd 2021",dateEndFifthStepPublish:"September 21st 2021",remainingDaysToSecondStep:"4 days",secondStepPassed:!1,currentStepOfPublishingProcess:2,editedByType:null,kuFlag:!1,biosketch:"The principal investigator and academic expert in epidemiological methods and evidence-based health with an emphasis on children's health. His research interests lie in the areas of Maternal-Child Health, Neonatal Care, and Environmental Health. From 2010 until 2017 he was Director of the Evidence-Based Health Office and currently serves as Director of the Nursing Institute at the Universidad Austral de Chile.",coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"88861",title:"Dr.",name:"R. Mauricio",middleName:null,surname:"Barría",slug:"r.-mauricio-barria",fullName:"R. Mauricio Barría",profilePictureURL:"https://mts.intechopen.com/storage/users/88861/images/system/88861.jpg",biography:"R. Mauricio Barría, DrPH, is a Principal Investigator and Associate Professor at the Faculty of Medicine at Universidad Austral de Chile. He was trained as an epidemiologist and received his MSc in Clinical Epidemiology from Universidad de la Frontera in Temuco, Chile, and his DrPH from Universidad de Chile in Santiago, Chile. His research interests lie in the areas of Maternal-Child Health, Neonatal Care and Environmental Health. He is skilled in epidemiological studies designs with special interest in cohort studies and clinical trials. Since 2010 until 2017 he was Director of the Evidence-Based Health Office and currently serves as Director of the Nursing Institute at the Universidad Austral de Chile. He has published several articles related to the care and health of the newborn and is a reviewer of several international journals.",institutionString:"Austral University of Chile",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"4",totalChapterViews:"0",totalEditedBooks:"4",institution:{name:"Austral University of Chile",institutionURL:null,country:{name:"Chile"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"16",title:"Medicine",slug:"medicine"}],chapters:null,productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"345821",firstName:"Darko",lastName:"Hrvojic",middleName:null,title:"Mr.",imageUrl:"//cdnintech.com/web/frontend/www/assets/author.svg",email:"darko@intechopen.com",biography:null}},relatedBooks:[{type:"book",id:"6550",title:"Cohort Studies in Health Sciences",subtitle:null,isOpenForSubmission:!1,hash:"01df5aba4fff1a84b37a2fdafa809660",slug:"cohort-studies-in-health-sciences",bookSignature:"R. Mauricio Barría",coverURL:"https://cdn.intechopen.com/books/images_new/6550.jpg",editedByType:"Edited by",editors:[{id:"88861",title:"Dr.",name:"R. Mauricio",surname:"Barría",slug:"r.-mauricio-barria",fullName:"R. Mauricio Barría"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5821",title:"Selected Topics in Neonatal Care",subtitle:null,isOpenForSubmission:!1,hash:"711594f833d5470b73524758472f4d96",slug:"selected-topics-in-neonatal-care",bookSignature:"R. Mauricio Barría",coverURL:"https://cdn.intechopen.com/books/images_new/5821.jpg",editedByType:"Edited by",editors:[{id:"88861",title:"Dr.",name:"R. Mauricio",surname:"Barría",slug:"r.-mauricio-barria",fullName:"R. Mauricio Barría"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8728",title:"Update on Critical Issues on Infant and Neonatal Care",subtitle:null,isOpenForSubmission:!1,hash:"52c4dbe7c0deb54899657dc4323238d6",slug:"update-on-critical-issues-on-infant-and-neonatal-care",bookSignature:"René Mauricio Barría",coverURL:"https://cdn.intechopen.com/books/images_new/8728.jpg",editedByType:"Edited by",editors:[{id:"88861",title:"Dr.",name:"R. Mauricio",surname:"Barría",slug:"r.-mauricio-barria",fullName:"R. Mauricio Barría"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6191",title:"Selected Topics in Breastfeeding",subtitle:null,isOpenForSubmission:!1,hash:"3334b831761ffa52e78de6fc681e33b3",slug:"selected-topics-in-breastfeeding",bookSignature:"R. Mauricio Barría P.",coverURL:"https://cdn.intechopen.com/books/images_new/6191.jpg",editedByType:"Edited by",editors:[{id:"88861",title:"Dr.",name:"R. Mauricio",surname:"Barría",slug:"r.-mauricio-barria",fullName:"R. Mauricio Barría"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophanides",surname:"Theophile",slug:"theophanides-theophile",fullName:"Theophanides Theophile"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1373",title:"Ionic Liquids",subtitle:"Applications and Perspectives",isOpenForSubmission:!1,hash:"5e9ae5ae9167cde4b344e499a792c41c",slug:"ionic-liquids-applications-and-perspectives",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/1373.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"57",title:"Physics and Applications of Graphene",subtitle:"Experiments",isOpenForSubmission:!1,hash:"0e6622a71cf4f02f45bfdd5691e1189a",slug:"physics-and-applications-of-graphene-experiments",bookSignature:"Sergey Mikhailov",coverURL:"https://cdn.intechopen.com/books/images_new/57.jpg",editedByType:"Edited by",editors:[{id:"16042",title:"Dr.",name:"Sergey",surname:"Mikhailov",slug:"sergey-mikhailov",fullName:"Sergey Mikhailov"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"68819",title:"Genetic Polymorphism and Alcohol Metabolism",doi:"10.5772/intechopen.88907",slug:"genetic-polymorphism-and-alcohol-metabolism",body:'\nAlcohol abuse and alcoholism represent substantial problems that affect a large portion of individuals throughout the world. More than 200 disease and injury conditions are caused by alcohol consumption due to liver cirrhosis, cancer and various injuries [1]. According to Organization for Economic Cooperation and Development (OECD) report released in May 2015, alcoholism has been increased by about 55% between 1992 and 2012. It is a quickly rising concern among the youth of the country. According to WHO [2], alcohol per capita consumption increased in China and India (China: 4.1, 7.1 and 7.2 liters in 2005, 2010 and 2016 respectively; India: 2.4, 4.3 and 5.7 liters in 2005, 2010 and 2016 respectively). By 2025, the highest increase in per capita alcohol consumption is expected in India and China covering largest population of South-East Asia and Western Pacific region. Table 1 indicates Indian scenario of alcohol consumption.
\nState/UT | \nToddy and country liquor (ml) | \nBeer, imported alcohol, wine (ml) | \nState/UT | \nToddy and country liquor (ml) | \nBeer, imported alcohol, wine (ml) | \n
---|---|---|---|---|---|
Andaman and Nicobar Island | \n656 | \n532 | \nLakshadweep | \n0 | \n0 | \n
Andhra Pradesh | \n561 | \n104 | \nMadhya Pradesh | \n133 | \n12 | \n
Arunachal Pradesh | \n749 | \n346 | \nMaharashtra | \n65 | \n19 | \n
Assam | \n304 | \n19 | \nManipur | \n155 | \n6 | \n
Bihar | \n266 | \n17 | \nMeghalaya | \n74 | \n49 | \n
Chandigarh | \n37 | \n42 | \nMizoram | \n29 | \n2 | \n
Chhattisgarh | \n120 | \n27 | \nNagaland | \n159 | \n23 | \n
Dadra and Nagar Haveli | \n2533 | \n498 | \nOrissa | \n146 | \n20 | \n
Daman and Diu | \n252 | \n1079 | \nPondicherry | \n154 | \n144 | \n
Delhi | \n55 | \n86 | \nPunjab | \n141 | \n50 | \n
Goa | \n47 | \n108 | \nRajasthan | \n80 | \n43 | \n
Gujarat | \n53 | \n3 | \nSikkim | \n41 | \n307 | \n
Haryana | \n89 | \n43 | \nTamil Nadu | \n20 | \n85 | \n
Himachal Pradesh | \n149 | \n73 | \nTripura | \n163 | \n2 | \n
Jammu and Kashmir | \n32 | \n7 | \nUttar Pradesh | \n34 | \n5 | \n
Jharkhand | \n320 | \n14 | \nUttarakhand | \n38 | \n43 | \n
Karnataka | \n23 | \n102 | \nWest Bengal | \n74 | \n12 | \n
Kerala | \n94 | \n102 | \n\n | \n | \n |
State-wise alcohol consumption per capita per week in India [7].
Approximately 80% of the college students consume alcohol which can have short- and long-term consequences including increased risk of accidental injury, risky sexual behavior, and lower education attainment. Alcohol use stimulates the Hypothalamic-Pituitary-Adrenal (HPA) axis and causes stress-like cortisol responses [3, 4]. Frequent stimulation of the HPA by alcohol may alter the function of the system, setting the stage for reduced activity to stressors and increased likelihood of alcohol use disorder. Moreover, abnormal stress physiology is related to greater addiction severity, cravings, and poor treatment outcome alcohol use disorder [5]. More than 90% of people who drink heavily develop fatty liver, a type of liver disease. Yet only 20% will go on to develop the more severe alcoholic liver disease and liver cirrhosis [6]. Environmental factors and genetic differences in the way alcohol is metabolized, also contribute to the development of alcoholic pancreatitis [8]. Genetic factors, for example, variation in enzyme activity that metabolize alcohol and environmental factors, for example, quantity of alcohol and overall nutrition a person consume play an important role in the etiology of alcoholic liver disorders including liver cancer. It has been reported that in the population of Central India who consume alcohol are at risk for liver disorders due to ALDH2, GSTM1 and GSTT1 gene polymorphism [9, 10].
\nThis article mainly focuses on the consequences of alcohol consumption at genetic level that ultimately affect alcohol metabolism resulting in various health disorders.
\nThere are two categories of alcoholic beverages, fermented (beer and wine) and distilled (whiskey, rum, gin, vodka etc.) and the concentration of ethanol differs across preparation. Yeast fermented alcoholic drinks generally contain less concentration of alcohol since yeast stops growing at about 15% ethanol concentration while strong alcoholic drinks/liquors are prepared through distillation [11].
\nMost alcoholic beverages mainly contain ethanol and water. Some beverages like beer, wine, spirit contain volatile and non-volatile substances along with ethanol. Volatile compounds include hydrocarbons, aliphatic carbon compounds, monocarboxylic acids esters, compounds having sulfur and nitrogen, benzene etc. Dibasic carboxylic acids, tribasic carboxylic acids, coloring agents, inorganic salts polyphenols, tannic acid etc. are the non-volatile substances [12]. Contaminants and toxins found are nitrosamines, mycotoxins, ethyl carbamate, pesticides, thermal processing contaminants, benzene, and inorganic contaminants include lead, cadmium, arsenic, copper, chromium, inorganic anions, and organometals [12].
\nRegardless of how much a person consume, the body can only metabolize a certain amount of alcohol every hour. That amount varies widely among individuals and depending on liver size and body mass [13]. The effects of alcohol on various tissues depend on blood alcohol concentration (BAC) over time. The time of alcohol absorption, distribution, metabolism and excretion determines BAC [14]. After absorption from small intestine, alcohol reaches liver for metabolism. The rate of BAC rise depends on how quickly alcohol is emptied from the stomach and its metabolism during first pass through stomach and liver [15, 16]. BAC depends on various factors viz. the presence of food in the stomach, alcoholic beverages, the rate of alcohol drinking and genetic polymorphism of alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH). Depending upon age, diet, alcohol consumption and smoking, the rate of alcohol elimination varies from individual to individual [17].
\nIn the developing world, alcohol use is one of the prevalent habit and is responsible for liver cancer [18, 19, 20]. Heavy drinking along with smoking increase the risk of developing cancers [21]. Observations suggest that some people develop cancer even at moderate daily alcohol consumption indicating that alcohol metabolism is genetically determined [22]. Also, those who typically consumed more than two drinks per drinking day were at increased risk of high blood pressure, high triglycerides, increased abdominal girth, and elevated blood glucose. Further, excessive per-occasion consumption is the primary risk factor for both acute and chronic alcohol-related problems [23].
\nThe pharmacologic and potentially pathologic effects of alcohol depend on the concentration of ethanol and its metabolites in the body, and on the duration of exposure to these substances. Alcohol is metabolized in the body by various mechanisms, that is, oxidative pathways involving alcohol dehydrogenase (ADH), aldehyde dehydrogenase (ALDH), cytochrome P450, and catalase enzymes (which either add oxygen or remove hydrogen) and non-oxidative pathways.
\nMost of the alcohol that people drink is metabolized in the liver. First, alcohol is oxidized to acetaldehyde by alcohol dehydrogenase (ADH). Acetaldehyde is highly toxic to the body, even in low concentrations. In the second step, acetaldehyde is further metabolized by ALDH to acetate and eventually to acetyl CoA, which then is broken down into water and carbon dioxide for easy elimination (Figure 1). Thus depending on the nutritional, hormonal, energetic status, the acetyl CoA is converted to CO2, ketone bodies, fatty acid and Cholesterol [14].
\nOxidative pathway of alcohol metabolism [17].
Acetaldehyde has the power to cause tremendous damage regardless of its short life. This is particularly evident in the liver, where major alcohol metabolism occurs [17]. Minor alcohol metabolism also takes place in the pancreas [24] and the brain, causing damage to cells and tissues [13]. Additionally, small amount of alcohol is metabolized to acetaldehyde in the gastrointestinal tract, exposing it to damaging effects [22]. The International Agency for Research on Cancer [25] asserts that acetaldehyde should be classified as a carcinogen, it promotes cancer in several ways, for example, by interfering with replication of DNA and by inhibiting a process by which the body repairs damaged DNA [22]. Studies have shown that people who are exposed to large amounts of acetaldehyde are at greater risk for developing cancer of the mouth and throat [22].
\nAcetaldehyde possesses the ability to bind to various proteins like enzymes, microsomal proteins and microtubules. It combines with neurotransmitter dopamine and form salsolinol that cause alcohol dependence and also form DNA adducts, for example, 1,N2-propanodeoxyguanosine which is carcinogenic [17]. However it is also reported that acetaldehyde concentrations in the brain are not high enough to produce these effects [26]. This is because the brain has a unique blood–brain barrier, which protects it from toxic products circulating in the bloodstream. However, it is possible that due to alcohol metabolism, acetaldehyde is produced in the brain by catalase [27, 28] and CYP2E1 [29].
\nAcetaldehyde may also be responsible for some of the behavioral and physiological effects previously attributed to alcohol [30]. For example, when acetaldehyde is administered to lab animals, it leads to in-coordination, memory impairment and sleepiness effects often associated with alcohol [26]. Deficiency of aldehyde dehydrogenase (ALDH2) leads to accumulation of acetaldehyde which results in facial flushing or blotches associated with erythema on the face, neck, shoulders, and in some cases, the entire body [31].
\nOxidation of acetaldehyde produce acetate which is later oxidized to carbon dioxide (CO2) in the heart, brain and skeletal muscles. Acetate is also metabolized to acetyl CoA, which is involved in lipid and cholesterol biosynthesis in the mitochondria of peripheral and brain tissues. Acetate causes depression in the central nervous system and also affects various metabolic processes [17].
\nEthanol is non-oxidatively metabolized by two pathways; first reaction is catalyzed by the enzyme fatty acid ethyl ester (FAEE) synthase leads to the formation of molecules known as FAEEs. In the second pathway, reaction with the enzyme phospholipase D (PLD) results in the formation of a phospholipid known as phosphatidyl ethanol [32]. This pathway is a critical component in cellular communication.
\nAlcohol metabolism involves both oxidative and non-oxidative inter related pathways. When ethanol oxidation is inhibited through enzyme inhibition, non-oxidative metabolism is increased along with increase in FAEEs in the liver and pancreas [33].
\nAlcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) are the main enzymes of alcohol metabolism. Both the enzymes have several forms encoded by different genes. Enzymes with different characteristics having different ethnic distributions are because of variants of these genes. Since these enzyme variants work efficiently than others suggesting some people can metabolize alcohol more quickly, for example, a fast ADH enzyme or a slow ALDH enzyme may increase acetaldehyde level resulting in deleterious health effects including alcohol dependence [34].
\nA null allele is a mutant copy of a gene at a locus that completely lack normal function. This can result in to complete absence of the gene product (protein, RNA), or the expression of a non-functional gene product. At the phenotypic level, a null allele is indistinguishable from a deletion of the entire locus [35].
\nBecause of genetic difference in these enzymes, alcohol related problems are either higher or lower in some ethnic groups, for example, ADH1B*2, a variant of ADH is common in people of China, Japan and Korea but rare in Europe and Africa [36]. Another version of the ADH enzyme ADH1B*3, occurs in 15–25% of African Americans [37]. These enzymes protect against alcoholism [38] by elevating the level of acetaldehyde that make drinking unpleasant [39]. Two variations of the ALDH enzyme, ALDH1A1*2 and ALDH1A1*3, may be associated with alcoholism in African-American people [40].
\nAlong with genetic factors, environmental factors are also important for alcoholism and alcohol-related health problems, for example, alcohol consumption increased from 2.5 to 13% in Japanese alcoholics who carried the protective ADH1B*2 gene [41]. There is no difference in the rate of alcohol metabolism and enzyme pattern between Native Americans and Whites, more Native American people die of alcoholism than any other ethnic group in the United States [42]. This suggests that a rate of alcoholism and alcohol-related problems depends on environmental and genetic factors.
\nThe major pathway of oxidative metabolism of ethanol in the liver involves ADH present in the cytosol. During oxidation an electron carrier nicotinamide adenine dinucleotide (NAD) is reduced to NADH providing reduced cytosolic environment in the liver cells. Because of byproduct like highly reactive and toxic free radicals and acetaldehyde, the liver cells become more vulnerable to damage [17]. Control of ADH activity is complex and involves: (a) dissociation of the product NADH which is a rate limiting step and (b) product inhibition by NADH and acetaldehyde [14].
\nADH comprises of a complex family. In humans on the basis of kinetic and structural properties, enzyme ADH has been categorized into five classes. Most of them are found in liver, stomach and lungs except ADH5 found in most tissues [17]. If alcohol concentration is high, it is eliminated at a higher rate because of high activity of enzymes viz. class II ADH encoded by ADH4 gene and β3-ADH encoded by ADH1B*3 gene [43].
\nAldehyde dehydrogenase (ALDH2) rapidly metabolizes acetaldehyde (produced by alcohol oxidation) to acetate and NADH. NADH is then oxidized through electron transport chain, or respiratory chain enzymes [17]. Among various isozymes of ALDH, only the cytosolic ALDH1 and the mitochondrial ALDH2 can metabolize acetaldehyde [44, 45].
\nGenetic polymorphism in ADH1B and ADH1C gene locations is associated with different levels of enzyme activity [46]. In different population ADH1B occur at different frequencies. For example, in Caucasian and black populations it is predominant, whereas in Chinese, Japanese and in some people of Jewish ancestry ADH1B*2 frequency is higher. In case of Caucasian populations, ADH1C*1 and ADH1C*2 appear with equal frequency [47]. People of Jewish descent carrying the ADH1B*2 allele show only marginally (<15%) higher alcohol elimination rates compared to people with ADH1B*1. Also, African Americans [48] and native Americans with the ADH1B*3 allele metabolize alcohol at a faster rate than those with ADH1B*1 [49].\n
\nVariants in both ADH and ALDH2 genes can influence alcohol metabolism by either increasing turnover of ethanol to acetaldehyde or deactivating oxidization function of acetaldehyde to harmless acetic acid [34, 50]. This can result in accumulation of acetaldehyde, which is a known mutagen and carcinogen that cause DNA damage and promote esophageal squamous cell carcinoma (ESCC) development [51]. In addition, ADH and ALDH2 alleles may influence individual alcohol consumption habits and risk of alcoholism development.
\nInformation on alcohol consumption, sex, and family history is essential in risk analyses of alcohol-related variants for several reasons. First, alcohol consumption could be a strong confounding variable and effect modifier in comparing genotypes and the risk of ESCC because genotypes and alcohol consumption are interrelated. Second, alcohol-related enzymes do not play a major role in ESCC development among alcohol nondrinkers, or females who drink lesser alcohol than males. Also the adverse role of loss-of-functional ADH and ALDH variants will increase in alcohol drinkers. Third, the mechanism of tumorigenesis may not be same with and without a family history of the esophageal cancer [52, 53].
\nThe allelic variants ALDH2*1 and ALDH2*2 resulted from genetic polymorphism of ALDH2 gene is inactive showing no acetaldehyde metabolism in vitro. After alcohol consumption level of acetaldehyde is high in people having heterozygous or homozygous condition for ALDH2*2 allele [44, 45] and therefore experience negative physiological responses to alcohol.
\nCytochrome P450 enzymes are present in almost all tissues of the body and play important roles in hormone synthesis and breakdown including estrogen and testosterone, cholesterol synthesis and vitamin D metabolism. Cytochrome P450 enzymes also function to metabolize potentially toxic compounds, for example, drugs and bilirubin, principally in the liver [54]. The cytochrome P450 isozymes, including CYP2E1, 1A2, and 3A4 which are present predominantly in the microsomes or endoplasmic reticulum, also contribute to alcohol oxidation in the liver. However, CYP2E1 is active only after a person consume large amount of alcohol, and catalase metabolizes only a small fraction of alcohol in the body [47]. This enzyme is induced when alcohol concentration is high and it metabolizes alcohol in to acetaldehyde. It also oxidizes alcohol in tissue like brain where ADH activity is low. It produces ROS which increase the risk of tissue damage [17]. When alcohol is metabolized by CYP2E1, highly reactive oxygen containing molecules or reactive oxygen species (ROS) is produced. ROS can damage proteins and DNA or interact with other substances to create carcinogenic compounds [55].
\nCYP2E1 enzyme is an important member of the cytochrome P450 family. It is a naturally ethanol-inducible enzyme involved in alcohol metabolism. Polymorphism in RsaI/PstI in the promoter gene region increases transcriptional activity of the gene which may play an important role in the development of esophageal carcinoma [56].
\n\nCYP2E1 c1/c1 genotype found at increased risk for gastric cardia cancer (GCC). Individuals with this genotype and have a history of heavy cigarette smoking were at increased risk for GCC. This suggests that the interaction of the CYP2E1 polymorphism with smoking has a great influence on susceptibility to GCC [57]. Polymorphisms in CYP2E1 involved in the metabolism of carcinogens tobacco and alcohol, leads to Head and Neck Squamous Cell Carcinoma (HNSCC). Haplotype analysis revealed that haplotype T-A was associated with a greater than 10-fold increase in risk for HNSCC. Use of alcohol or tobacco interact with CYP2E1 variant genotypes or with GSTM1 or XRCC1 and increases the risk of HNSCC suggest the importance of gene–gene and gene–environment interactions in the development of HNSCC [58].
\nThere was no risk of ESCC found associated with CYP2A6, CYP2E1, GSTM1 polymorphism suggest an opposite role of GSTP1 and GSTT1 polymorphisms for ESCC [59]. Gene polymorphism in GSTM1, GSTT1, GSTP1, CYP1A1 and CYP2E1 represent risk-modifying factors for ethanol related diseases in Brazilian alcoholics and controls with similar ethnic backgrounds. Also the persons with these genotypes are genetically more prone to the development of alcoholic pancreatitis and alcoholic cirrhosis, respectively [60, 61, 62, 63].
\nCatalase (in peroxisomes) is capable of oxidizing ethanol in vitro in the presence of a hydrogen peroxide (H2O2) generating system, such as the enzyme complex NADPH oxidase or the enzyme xanthine oxidase. It converts hydrogen peroxide into water and molecular oxygen. Quantitatively, however, this is considered a minor pathway of alcohol oxidation, except in the fasted state [64].
\nCAT pathway plays a prominent role in the oxidation of ethanol in the brain [17]. A common polymorphism in the promoter region of the catalase gene CAT c.-262C > T (rs1001179) influences the susceptibility to alcohol dependence and severity of alcohol dependence [65]. It was found that CAT levels were significantly higher in subjects carrying CAT -262 T allele [66, 67]. There is one study showing CAT activity and alcohol intake are interrelated [68], but the impact of this polymorphism in alcohol dependence needs to be investigated for proper conclusions [67].
\nEpilepsy is one of the chronic brain disorders characterized by recurrent seizures due to abnormal excessive electrical discharges of cerebral neurons [1]. It is believed that genetic factors play a crucial role in the etiopathogenesis of epilepsy. So far ~1000 genes have been proved to be associated with epilepsy, among which genes encoding VGIC predominate [2].
VGICs are pore-forming membrane proteins. Their functions include establishing APs and maintaining homeostasis by gating the ionic flow traversing the cell membrane, managing the ionic flow across cells and regulating Ca2+ signal transduction, which are essential to the neuroexcitability, so VGICs are potentially involved in epileptogenesis [2]. The association of VGIC genes and epilepsy might provide insights into the etiopathogenesis underlying epilepsy. Pathophysiological studies illuminated that two key defects are (i) a neuronal disinhibition induced by loss-of-function of VGIC gene expressed specifically in inhibitory interneurons (for example, Nav1.1 and P/Q VGCCs) or (ii) dysfunction of axon initial segments, the neuronal structure in which APs are generated and many VGICs (such as Nav1.2 and Kv7) are mainly localized (Figure 1). Moreover, clinically originated studies identified novel genes, defined their neuronal functions, and sometimes established novel physiological principles [2].
Neuronal localization of some relevant voltage-gated ion channels. A schematic view of an excitatory pyramidal (orange), an inhibitory (green) neuron, and their synaptic connections is shown. Distinctive intracellular compartments are targeted by different populations of VGICs. Examples of which as mentioned in this chapter are shown here: in the somatodendritic compartment, Nav, Cav (L- and T-type), TRP, BK, and Kv channels; at axon initial segments (AIS) and nodes of Ranvier in pyramidal neurons, Nav1.2, Kv7 channels; at AIS of inhibitory neurons, Nav1.1; in the somatodendritic compartment of inhibitory neurons, BK and Nav1.6; in the presynaptic terminals, Cav P/Q type. GOF represents the gain-of-function mutation of VGICs-induced human epilepsy. LOF represents the loss-of-function mutation of VGICs.
In this chapter, we summarize the epilepsy-associated VGIC genes, the mutations, corresponding phenotypes, and functional changes, aiming to provide clues for evaluating the relationship between VGIC genes and epileptogenesis.
VGSCs play a critical role in the generation and propagation of APs in neurons, genetic alterations in VGSC genes are considered to be associated with epileptogenesis. Mammalian VGSC is composed of a large pseudotetrameric pore-forming α subunit with a molecular weight of 260 KDa, and one or more auxiliary β subunits (30–40 KDa) [3, 4, 5] (Figure 2). Nine subtypes of VGSC α subunits have been found in humans, including Nav1.1-Nav1.9, encoded by the genes SCN1A-SCN5A, SCN8A-SCN11A, respectively.
Structure of voltage-gated sodium channels. Schematic representation of VGSC subunits. The α subunit of the VGSC is illustrated together with β1 and β2 subunits; extracellular domains of the β subunits are shown as immunoglobulin-like folds, interacting with the loops in α subunits. Roman numerals indicate the domains of the α subunit; segments 5 and 6 (shown in green) are the pore-lining segments, and S4 helices (red) make up the voltage sensors. The red circle in the intracellular loop of domains III and IV indicates the inactivation gate IFM motif; Ψ, probable N-linked glycosylation site. The circles in reentrant loops in each domain represent the residues that form the ion selectivity filter.
Nav1.1 is mainly distributed in the inhibitory GABAergic neurons of cerebellum and hippocampus. The Nav1.1 gene SCN1A is the clinically most relevant SCN gene for epilepsy. More than 1200 mutants have been identified to be associated with epilepsy; most of them are febrile seizures [6]. M145T mutation, a well-conserved amino acid in the first transmembrane segment of domain I of the Nav1.1 α-subunit, caused a reduction in peak sodium currents and a positive shift in the voltage dependence of activation [7], which provided the first evidence that the mild loss-of-function mutations in Nav1.1 may cause a significant portion of febrile seizures. Complete loss-of-function mutations in Nav1.1 cause severe myoclonic epilepsy of infancy (SMEI or Dravet’s syndrome), which includes severe, intractable epilepsy and comorbidities of ataxia and cognitive impairment. Besides, homozygous null Nav1.1−/− mice developed ataxia and died on half a month of postnatal and did not change the voltage-dependent activity of VGSCs in hippocampal neurons. However, heterozygous Nav1.1+/− mice exhibited spontaneous seizures and sporadic deaths after 3 weeks, and the sodium current density was substantially reduced in inhibitory interneurons, except in excitatory pyramidal neurons [8]. So loss-of-function mutations in Nav1.1 can severely impair sodium currents and AP firing in hippocampal GABAergic inhibitory neurons. The functional downregulation in inhibitory neurons might cause the hyperexcitability of dentate granule or pyramidal neurons, which could lead to epilepsy in patients with SMEI. Experiments in mice have demonstrated that haploinsufficiency of Nav1.1 channels is sufficient to allow induction of seizures by elevated body temperature, supporting that haploinsufficiency of SCN1A is pathogenic in human SMEI which has striking temperature and age dependence of onset and progression of epilepsy [9]. What is more, SCN1A mutations were mostly missense mutations in GEFS+ patients, which are typically well controlled by treatment with antiepileptic drugs and no cognitive impairment is observed. The R1648H channels showed the reduced function in both excitatory and inhibitory neurons although the biophysical mechanisms were different, reducing peak sodium currents and enhancing slow inactivation in inhibitory neurons versus negatively shifted voltage dependence of fast inactivation in excitatory neurons [10]. The similar conclusion had been drawn when the R1648H mutation has been inserted into the mouse genome under the native promoter [11]. In light of these results, GEFS+ and SMEI may be caused by a continuum of mutational effects that selectively impair firing of GABAergic inhibitory neurons, which lead to increase in the excitability of the neural network [12].
The mutation of the Nav1.2 gene SCN2A is associated with various epilepsies, such as benign familial neonatal seizures (BFNIS), hereditary epilepsy with febrile seizures plus (GEFS+), Dravet’s syndrome (DS), and other stubborn childhood epilepsy encephalopathy. Nav1.2 subunit is mainly distributed in the axon-initiating segment (AIS) and node of Ranvier. SCN2A mutations cause changes in VGSC function and expression and result in abnormal neuronal discharge. Because Nav1.2 plays an important role in the AIS area during the development, it is more common for infants to show SCN2A mutant-induced epilepsy encephalopathy [13]. BFNIS is the most common phenotype caused by gain-of-function missense mutations in SCN2A [14]. Up to now, at least 10 SCN2A mutations associated with BFNIS have been identified. SCN2A mutations are also found to result in the reduced expression of Nav1.2 on the surface of neurons [15]. Therefore, SCN2A mutants will lead to the decrease of sodium current density at node of Ranvier and AIS, seriously affecting the excitability of neurons [16]. For missense mutation of SCN2A, p.Tyr1589Cys causes a depolarizing shift of steady-state inactivation, increased persistent Na+ current, a slowing of fast inactivation, and an acceleration of its recovery, which contribute to neuronal hyperexcitability and familial epilepsy [17]. Due to the SCN2A mutation, early infantile epileptic encephalopathy (EIEE) patients with burst suppression and tonic-clonic migrating partial seizures showed a specific dose-dependent efficacy of VGSC blockers [18]. It is mainly caused by the dysfunction of VGSC [19]. By replacing neonatal Nav1.2 with adult Nav1.2 in mice, it has been suggested that neonatal Nav1.2 reduced neuronal excitability and had a significant impact on seizure susceptibility and behavior.
The SCN3A gene, clustered on human chromosome 2q24, encodes the Nav1.3 subtype [20], which is usually located in the soma of neurons. It is important in the integration of synaptic signals, determination of the depolarization threshold, and AP transmission [21]. In contrast to the rodent gene which is transiently expressed during development, human SCN3A is widely expressed in adult brain [22]. The first epilepsy-associated mutation (K354Q) in SCN3A was found in 2008. K354Q mutation decreased inactivation rate and increased INaP [23]. The mutation is not sensitive to antiepilepsy drug carbamazepine or oxcarbazepine. K354Q mutation causes neuronal abnormal spontaneous discharge and membrane potential paroxysmal depolarization [24]. In 2014, four more missense variants were identified in SCN3A, which are R357Q, D766N, E1111K, and M1323V [25]. Compared to wild-type channels, R357Q caused smaller currents, slower activation, and depolarized voltage dependences of activation and inactivation. The E1111K mutation evoked a significantly greater level of persistent sodium current. All four mutants increase current activation in response to depolarizing voltage ramps. These findings support for a contribution of Nav 1.3 to childhood epilepsy. Recently, a novel SCN3A variant (L247P) was identified by whole exome sequencing of a child with focal epilepsy, developmental delay, and autonomic nervous system dysfunction. Voltage clamp analysis showed no detectable sodium currents in a heterologous expression system. To further test the possible clinical consequences of reduced SCN3A activity, they investigated the effect of a hypomorphic Scn3a allele (Scn3a Hyp) on seizure susceptibility and behavior using a gene trap mouse line. Heterozygous SCN3A mutant mice (SCN3A+/Hyp) neither exhibit spontaneous seizures nor hyperthermia-induced seizures, but they displayed increased susceptibility to electroconvulsive- and chemiconvulsive-induced seizures, which provide evidence that loss-of-function of SCN3A may contribute to increased seizure susceptibility [26].
Nav1.6, mainly distributed to the soma and synaptic origin, is important for APs generation and propagation [27]. In the development process, Nav1.2 is gradually replaced by Nav1.6 in the mature node of Ranvier [28]. The first heterozygous missense mutation (p.Asn1768Asp) in the Nav1.6 gene SCN8A was identified in 2012 by whole-genome sequencing (WGS) in a patient with severe epileptic encephalopathy who exhibited early-onset seizures, autistic features, intellectual disability, ataxia, and sudden unexpected death in epilepsy (SUDEP) [29]. Since this initial discovery, more than 100 pathogenic SCN8A variants have been identified in patients with epilepsy [30]. Most of the SCN8A variants have been detected in individuals with EIEE.
Different mutations in the SCN8A gene encoding Nav1.6 have different effects on epilepsy. For the missense mutation V929F, an evolutionarily conserved residue in the pore loop of domain II of Nav1.6, it was found that heterozygous mutations produced well-defined spike-wave discharges and are associated to absence epilepsy in mice [31]. However, missense mutations in Scn8amed−jo were able to improve the epilepsy symptoms of SCN1A+/− heterozygotes. The mechanism might be the decrease in Nav1.6 expression of excitatory neurons compensating for the loss of Nav1.1 in inhibitory neurons [32]. Recently, more and more de novo and inherited SCN8A epilepsy mutations were detected by gene panel analysis [33]. For example, loss-of-function mutants [34], underlying the complex seizure phenotype, were identified using specific mouse line. It was suggested that decreasing Scn8a expression in cortical excitatory neurons could reduce seizures. On the contrary, the decreasing expression of SCN8A in the thalamic reticular nucleus (RT) leads to absence seizures. Loss of Scn8a will impair tonic firing mode behavior and impair desynchronizing recurrent RT-RT synaptic inhibition in the thalamic reticular nucleus, which suggested that Scn8a-mediated hypofunction in cortical circuits, conferring convulsive seizure resistance, while hypofunction in the thalamus is sufficient to generate absence seizures.
The SCN9A gene encodes the Nav1.7 subtype, which was initially identified in the peripheral nervous system, sympathetic ganglion, and olfactory sensory neurons [35, 36, 37, 38]. Nav1.7 is also found expressed in the central nervous system such as in the cerebral cortex and hippocampus [39]. A missense mutation of SCN9A (N641Y), at a conserved amino acid residue located at the intracellular loop between domain I and II, is associated with a family of febrile seizures (FS, N641Y). Mice carrying N641Y mutations were more susceptible to electrical stimulation-induced clonic and tonic seizures [40]. However, it is still unclear how SCN9A gene mutation caused epilepsy in the CNS.
K+ channels control the resting membrane potential and enable rapid repolarization of the AP by producing outward K+ currents, thus limiting neuronal excitability. K+ channels are composed of four pore forming a subunits and modulatory b subunits. Kv channels are the largest ion channel group (Kv1–Kv12) that are expressed substantially in the CNS. Dysfunction of Kv channels including Ca2+-activated K+ channels, are associated with epilepsy [2].
Large conductance calcium-activated potassium (BK) channels, consisting of functional α subunit and the tissue-specific regulatory subunits (β1–4 and γ1–4), are widely distributed in the CNS. BK channels are usually considered as vital players in the development of epilepsy (Figure 3), with the evidence including the K+ derangement and regulating AP shape and duration [41, 42].
Yin and Yang of BK channels in epilepsy. For epilepsy suppression, BK (α) channels act as negative feedback regulators on calcium rise and transmitter release in most synapses. Activation of mitoBK channel subtypes (α or α+β4) may contribute to suppressing seizure as well as conferring neuroprotection via the inhibition of ROS synthesis [54]. For epilepsy promotion, astrocyte and OPCs BK channel subtypes (α+β1 or α+β4) may induce elevate [K+]o, causing membrane depolarization as well as neuronal hyperexcitation. Microglial BK channels (α+β3) may involve in the neuroinflammation during status epilepsy. Mutation D434G of α causes the neurohyperexcitation in hereditary epilepsy. However, ubiquitin ligase CRL4ACRBN could inhibit the overactivation of BK channels.
Gain-of-function mutation of BK, promoting the high-frequency neuron firing, is associated with spontaneous epileptic seizures paradoxically in both humans and rodents [43]. In fact, patients suffering from generalized epilepsy were detected a site mutation D434G at the RCK1 domain of BK α subunit. D434G increased the opening time of BK, through the enhancement of Ca2+ sensitivity [43]. In terms of functionality, the enhanced membrane excitability is associated with the increased BK activity and fAHP consequent [43, 44]. The augment seems to be induced by an increased recovery rate, underlying fast currents of VGSCs with a APs’ reduced refractory period and/or through disinhibiting thalamocortical circuits by blocking brain GABAergic interneurons [43, 45, 46].
The knockout mice of BK channel β4 subunit exhibit temporal lobe epilepsy (TLE) seizure associated with a gain-of-function phenotype of BK, which not only sharpens APs but also induces a higher neuronal firing frequency in hippocampus DG granule cells [47].It is worth mentioned that epileptic seizures themselves also could induce a gain-of-function effect to BK. Picrotoxin and pentylenetetrazol (PTZ) caused generalized tonic-clonic epileptic seizures, with giving rise to a gain-of-function effect on BK channels, presenting increased BK currents and neuron firing in the neocortex [48]. It is of interest that BK-specific inhibitors attenuated generalized tonic-clonic epileptic seizures in picrotoxin or PTZ-induced epilepsy models, which suppressed the increase of neuron firing [48, 49].
Loss-of-function phenotype of BK might also contribute to the pathological process of clinical TLE. It was reported that two siblings suffered from the severe cerebellar atrophy and developmental delay, who adopted the exome analysis that identified a homozygous frameshift duplication in BK gene KCNMA1 (c.2026dupT;p.(Tyr676 Leufs*7)) in children from a consanguineous family with epilepsy [50].
KCNMB3, encoding the auxiliary BK β3, mapping the human chromosome 3 (3q26.3-q27) [51], is duplicated in the dup (3q) syndrome, which is characterized by neurological abnormalities, especially epileptic seizures [51]. Because of the dup (3q) syndrome having early onset during developmental process, the KCNMB3 duplication implies that β3 subunits overexpression might contribute to the etiology of epilepsy. Similarly, site mutations might also contribute to both neurohyperexcitation by a single nucleotide deletion at KCNMB3 exon 4 (delA750), which is associated with the generalized epilepsy, especially in the form of the typical absence epilepsy [52]. BK coexpressed with β3 variant of β3b-V4 (delA750) shows fast inactivation properties [53], which suggest that BK currents were reduced and the repolarization of cell membrane was attenuated during an action potential, eventually leading to neurohyperexcitation.
Kv7 is its seventh member of Kv channel family (Kv1–Kv12). The Kv7.1 mutation mediates type 1 long QT syndrome (long-QT syndrome type 1, LQT1) and is therefore named KCNQ1 (K, potassium; CN, channel; Q, LQT). KCNQ has five subtypes of KCNQ1–KCNQ5, which play crucial roles in physiological functions. Dysfunction of KCNQ is associated with many diseases.
KCNQ1 is mainly distributed in the heart, which mediates cardiac delayed-rectifier K+ current and maintains the normal repolarization process of cardiomyocytes [55]. KCNQ2–KCNQ5 are mainly distributed in central and peripheral neuronal tissues, of which KCNQ2 and KCNQ3 are distributed in brain regions [56]. KCNQ2 and KCNQ3 form functional heterotetramers, which are the main molecular bases for the formation of M currents that can be inhibited by acetylcholine M1 receptor activation [57]. Abundant KCNQ2 and KCNQ3 mutations could induce abnormal M currents, causing similarities in neonatal seizures and other nervous system diseases.
Benign familial neonatal seizure (BFNS) is an autosomal dominant idiopathic epilepsy syndrome that occurs on the 2nd to 8th day after birth and stops spontaneously after a few weeks. Whereas 15% of patients in later life may have recurrence of epilepsy [58]. With the study of pathogenic genes in epilepsy, 60–70% of patients with BFNS were found to be associated with KCNQ2 and KCNQ3 mutations. More than 80 different mutations have been reported on KCNQ2, and multiple mutations on KCNQ3 are associated with BFNS. Soldovieri et al. [58] studied the genes of 17 BFNS clinical patients. Sixteen different heterozygous mutations were found in KCNQ2, including 10 substitutions, 3 insertions/deletions, and 3 large deletions. One substitution was found in KCNQ3. Most of these mutations were novel, except for four KCNQ2 substitutions that were shown to be recurrent. Electrophysiological studies in mammalian cells revealed that homomeric or heteromeric KCNQ2 and/or KCNQ3 channels carrying mutant subunits with newly found substitutions displayed reduced current densities. Borgatti studied a BFNS family with four affected members: two of them exhibit BFNS only, while the other two, in addition to BFNS, present either with a severe epileptic encephalopathy or with focal seizures and mental retardation. All affected members of this family carry a novel missense mutation in the KCNQ2 gene (K526N), disrupting the tridimensional conformation of a C-terminal region of the channel subunit involved in accessory protein binding. When heterologously expressed in CHO cells, potassium channels containing mutant subunits in homomeric or heteromeric configuration with wild-type KCNQ2 and KCNQ3 subunits exhibit an altered voltage-dependence of activation, without changes in intracellular trafficking and plasma membrane expression. The KCNQ2 K526N mutation might affect M-channel function by disrupting the complex biochemical signaling involving KCNQ2 C-terminus [59, 60]. KCNQ2 or KCNQ3 mutations cause M current to be downregulated, and the frequency of neuronal firing increases, leading to epilepsy.
Inward-rectifier potassium channels (Kir, IRK) are a specific subset of potassium channels. To date, seven subfamilies have been identified, which are associated with a variety of diseases [61]. The G-protein-coupled Kir (GIRK) channels belong to the subfamily of Kir3 (GIRKs) which are activated by ligand-stimulated G protein-coupled receptors (GPCRs). GPCRs, interacting with GIRK channels, facilitate their activation, resulting in hyperpolarization of the cell membrane [61].
GIRK channels have four identified subunits (GIRK1–4, encoded by KCNJ3, KCNJ6, KCNJ9, and KCNJ5, respectively) in mammals, existing in vivo both as homotetramers and heterotetramers with unique biophysical properties, regulation, and distribution [61, 62]. GIRK 1, 2, 3, and 4 subunits are expressed in the brain, localized in certain axons, postsynaptic, and presynaptic regions [63]. GIRK channels may be involved not only in slow inhibitory postsynaptic potentials but also in the presynaptic modulation of neuronal activity [61].
GIRK in the CNS is a heterotetramer composed of GIRK1 and GIRK2 subunits [63], which is responsible for maintaining the resting membrane potential and excitability of the neuron [64]. GIRK1 and GIRK2 subunits are found in the dendritic areas of neurons highly [63] correlate with the large concentration of GABAB receptors. Once the GABAB receptors are activated by their ligands, they can in turn activate IRK, mediating a significant part of the GABA postsynaptic inhibition [63].
Alterations in GIRK function have been associated with pathophysiology of severe brain disorders, including epilepsy. In this regard, a GIRK2 knockout mouse model resulted to be more susceptible to develop both spontaneous and induced seizures in respect to wild-type mice [65]. In particular, mice carrying a p Gly156Ser mutation displayed an epileptic phenotype [66]. Indeed, this mutation has been found to alter the putative ion-permeable, pore-forming domain of the channel, inducing Ca2+ overload in cells and reducing channel availability, leading thus to neurodegeneration and seizure susceptibility [67].
An increased expression of GIRK was observed in rat brain after an electroconvulsive shock, probably altering the excitability of granule cells and the functions of neurotransmitter receptors which are coupled to these channels [68]. Another evidence in support of a role of GIRK in epilepsy was provided by the demonstration that ML297, a potent and selective activator of GIRK, showed epileptogenic properties in mice [69]. On the other hand, the inhibition of GIRK activity by drugs causes seizures [70]. All these considerations imply that changes in Kir3 channel activity may alter the susceptibility to seizures.
As an important second messenger, Ca2+ plays a vital role in normal brain function and in the pathophysiological process of different neurodegenerative diseases. Ca2+ entry via VGCCs conveys the electric signals to intracellular transduction cascades in a wide variety of cells [71]. VGCCs were first identified by Fatt and Katz [72] and shown to consist of several subunits [73, 74]. VGCCs were divided into low-voltage-activated (LVA) and high-voltage-activated (HVA), based on electrophysiological and pharmacological properties. HVA channels, composed of α1, β, α2δ, γ subunit, are further divided into L, N, P, and Q types, which have an activation threshold at membrane voltage positive to −20 mV [75]. LVA channels, also called T type, consist only of the α1 subunit, activated at a membrane voltage positive to −70 mV. It is composed of transmembrane topology with four homologous transmembrane domains, each containing six transmembrane segments and a pore region between segments S5 and S6.
The L-type VGCC family has four members, Cav1.1–1.4, of which α subunits present tissue-specific expression, such as the α1D subunit in the brain. The L-type VGCC family shapes neuronal firing and activates Ca2+-dependent pathways involved in regulation of gene expression [76]. Cav1.2 channels appear to contribute critically to the generation of febrile seizures, which was proved by testing the excitability of hippocampal pyramidal cells in rat brain slices [77]. The Wistar Albino Glaxo/Rij (WAG/Rij) model experiments suggest that L-type calcium channels play a positive role in the frequency and duration of epileptic spikes [78]. Verapamil, an L-type VGCC blocker, could significantly reduce TLE seizure, enhancing the expression of the α subunit of γ-GABAAR [79].
P/Q-, N-, and R-type are corresponding to Cav2.1, Cav2.2, and Cav2.3, respectively, which initiate rapid synaptic transmission, regulated primarily by direct interaction with G proteins and SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) and secondarily by protein phosphorylation. The loss function of P/Q VGCC could lead to epileptic spikes, paroxysmal dystonia and ataxia. If P/Q VGCCs were blocked, it could disrupt the triggering synaptic neurotransmitter release [80]. Spikes of Cacna1aNtsr−/− mice are increased in layer VI corticothalamic neurons compared with control group, suggesting that Cav P/Q deletion generates absence epilepsy [81]. Cacna1a LOF from parvalbumin (PV)(+) and somatostatin (SST)(+) interneurons results in severe generalized epilepsy. It might be the mechanism for severe generalized epilepsy that the loss of Cav2.1 channel function from cortical PV(+) interneurons inhibits GABA release from these cells, which impairs their ability to constrain cortical pyramidal cell excitability [82]. When knocking out the cerebellar Cav2.1 channel in mice, cortical function is changeable, which caused movement disorders and epilepsy [83]. In two families with idiopathic epilepsy, the loss of function mutation in γ4 subunits, auxiliary subunit of Cav2.1 channels, could also cause seizures, and maybe aggravate seizures [84]. Downregulation of α2δ2 subunits in rats will generate 5–7 Hz epileptic wave accompanied by ataxia [85]. N-type calcium channels are mainly distributed in the nucleus of different neurons and glial cells. In the pilocarpine model, Cav2.2 expression decreased in the granule layer of the dentate gyrus and the pyramidal cells of the CA3 region during the acute phase of seizure. However, the expression of N-type calcium channels increased in the subsequent chronic phase, which demonstrated that the increase of N-type calcium channels might be associated with recurrent status epilepticus [86]. R-type calcium channel, Cav2.3, is mainly distributed in the presynaptic membrane, such as hippocampal mossy fibers, globus pallidus, and neuromuscular junctions. Knocking out R-type calcium channels could increase the susceptibility of seizures, with altering the seizure form [87]. The lack of Cav2.3 resulted in a marked decrease in the sensitivity of the animal to γ-butyrolactone-induced absence epilepsy and change thalamocortical network oscillations [88]. Administration of kainic acid revealed alteration in behavioral seizure architecture, dramatic resistance to limbic seizures and excitotoxic effects in Cav2.3−/− mice compared with controls. It indicated that the Cav2.3 plays a crucial role in both hippocampal ictogenesis and seizure generalization and is of central importance in neuronal degeneration after excitotoxic events [89].
T-type channels, widely distributed in the thalamus, are important for the repetitive firing of APs in rhythmically firing cells, which could be activated and inactivated more rapidly at more negative membrane potentials than other VGCCs [90]. Three subtypes of T-type channels have been identified, designated as Cav3.1, Cav3.2, and Cav3.3; they correspond to complexes containing the pore-forming α1 subunits, α1G, α1H, and α1I, respectively [91]. It has long been suggested that generalized absence seizures are accompanied by hyperexcitable oscillatory activities in the thalamocortical network [92]. The evidence that succinimide and related anticonvulsants could block thalamic T-type channels make researchers speculate that T-type Ca2+ channels might be related to the pathogenesis of spike-and-wave discharges (SWDs) in generalized absence seizures [93]. In the kainate epilepsy model, Cav3.1−/− mice display significantly reduced duration of seizures compared to wild type, but the frequency of seizures increased slightly [94]. In the WAG/Rij model, the expression of Cav3.1 may be related to age, and blocking Cav3.1 can reduce the onset of epilepsy [94, 95] which suggested that decrease in Cav3.1 channel expression and Ca2+ current component that they carry in thalamocortical relay neurons serves as a protective measure against early onset of SWD and absence seizures [96]. Notably, Cav3.1−/− mice are resistant to SWD seizures specifically induced by γ-GABABR agonists. Simultaneously, the γ-GABABR agonists induced only very weak and intermittent SWDs in Cav3.1−/− mice [97]. Cav3.2 single nucleotide mutation has been reported in patients with childhood absence epilepsy and other types of idiopathic generalized epilepsies [98, 99]. Gain-of-function mutations (C456S) in Cav3.2 channels increase seizure susceptibility by directly altering neuronal electrical properties and indirectly by changing gene expression [100].
Transient receptor potential (TRP) channels, which could induce a transient voltage changes to continuous light mutations of Drosophila melanogaster, are expressed in photoreceptors carrying trp gene. The first homologous human gene was reported in 1995. There are 30 trp genes, and more than 100 TRP channels have been identified so far, and TRP channels were divided into 7 subfamilies, including TRPC, TRPV, TRPM, TRPA, TRPP, TRPML, and TRPN. Focus on TRPs, one family of Ca2+ channels, plays a role in neuronal excitability. It is obviously known that Ca2+ is an important second messenger, which is related to the etiology of epilepsy [101]. Therefore, TRP channels are thought to be partially responsible for epileptic seizures, especially for TPRC and TRPV1 channels.
TRPC channels are the closet homolog to Drosophila TRP channels. Based on the functional comparisons and sequence alignments, four subsets of mammalian TRPCs (TRPC1, TRPC2, TRPC3/6/7, and TRPC4/5) have been generated [101]. These channels form receptor-modulated currents in the mammalian brain and important to SE-induced neuronal cell death. These channels could play a critical role in the generation of spontaneous seizures. TRPC1 and TRPC4 are expressed in CA1 pyramidal neurons. The amplitude of the plateau and the number of spikes were significantly reduced in mice without TRPC1 and TRPC4 [102]. TRPC3 channels are found to be responsible for pilocarpine-induced status epilepticus (SE) in mice. The reduction on SE in TRPC3 KO mice is caused by a selective attenuation of pilocarpine-induced theta wave activity [103]. TRPC7 can be detected in CA3 pyramidal neurons largely. The spontaneous seizures in CA3 pyramidal neurons and the pilocarpine-induced increase in gamma wave activities during the latent period could be significantly reduced by ablating the gene TRPC7 [104].
TRPV1 is one subfamily of TRP channels, expressing in most neurons. The expression of TRPV1 protein in epileptic brain areas was increased [105], but the epileptic activity in hippocampal slices was decreased by iodoresiniferatoxin (IRTX), a selective TRPV1 channel antagonist [106]. It is well known that glutamate could be released when the TRPV1 channel was activated [107], and the glutamate neurotransmitters are related to the etiology of epilepsy. Thus, focusing the TRPV1 channels activity may be important for the modulating neuronal excitability in epilepsy [106]. Recent studies showed that the high expression of TRPV1 channels could induce the temporal lobe epilepsy [105]. Cytosolic calcium elevation through activation of TRPV1 channels plays a physiologically relevant role in the regulation of epileptic seizures [108], decreasing the calcium accumulation by inhibiting the TRPV1 channels, could play a neuronal protective role against epilepsy-induced Ca2+ entry in hippocampal neurons. As mentioned above, the TRPV1 could be activated by hyperthermia; the hyperthermia-induced TRPV1 might be an effective candidate therapeutic target in heat-induced hyperexcitation [109, 110]. The activation of TRPV1 promotes glutamate release by increasing the excitability of neurons and synaptic terminals [111]. Whereas the activities would be reduced in hippocampus slices of rats after given the CPZ and ITRX, which were the TRPV1 channel blockers.
At present, the treatment of epilepsy is still dominated by drugs. More than 35% of marketed antiepileptic drugs target VGICs, such as phenytoin, carbamazepine, oxcarbazepine, and ethosuximide. Phenytoin and carbamazepine are broad-spectrum antiepileptic drugs blocking VGSCs as their primary mechanism of action. For example, phenytoin is a more effective inhibitor of SCN8A-I1327V than other drugs [112], which could be used in treating patients with gain-of-function mutations of SCN8A. Different types of VGCCs play different roles in the pathological process of epilepsy. Decreased expression of P/Q type could induce epilepsy, whereas increased expression of N-type and T-type calcium channels could lead to epilepsy. Calcium blockers including ethosuximide have been widely accepted for the treatment of absence epilepsy [71]. Gain-of-function BK channels contribute to epileptogenesis and seizure generation. BK-blocking agents, like paxilline [49], might be used as potential therapeutic drugs.
In the future, novel techniques might contribute to develop reasonable therapies for treating inherited or acquired epileptic syndromes. For instance, induced pluripotent stem cells (IPS) and genetically engineering animal models could be used for accurate treatments of epilepsy. Single-nucleotide polymorphisms (SNPs) of VGIC genes from hereditary epilepsy patients could be detected by de novo genomic sequencing. VGICs of IPS cells could be mutated by CRISPR-Cas9 according to the information of these SNPs [113]. Through inducing IPS cells differentiated into neurons, phenotype of VGIC gene SNPs could be well investigated. It is also a well-detection platform for selecting antiepileptic drugs that would be sensitive to mutated VGICs in vitro [112]. For in vivotests, besides transgenic mice, construction of nematode or zebrafish epileptic models may be creating a shortcut for choosing suitable and personalized antiepileptic drugs [114, 115]. In addition to drug control, optogenetics and ultrasonic control are hopeful to suppress the epileptic seizures induced by VGIC dysfunction [116, 117].
We systemically summarized the mutations and phenotype information of 21 epilepsy-associated VGIC genes. The dysfunctional VGICs are like the blasting fuse for neuronal hyperexcitability. We have good reason to believe that epilepsy-associated mutations of VGICs could be considered as a biomarker, which is possible to be one of the molecular bases underlying the classification of epilepsy syndromes identified by modern medicine. VGICs are the important targets for many antiepileptic drugs. Novel VGIC modulators are potentially effective strategy for the development of novel antiepileptic drugs. Individualized precise treatment using matching VGIC drugs will provide novel research directions and antiepileptic strategies.
This work was supported by National Science Foundation of China (Nos. 81603410 and 31771191), Innovation Fund of Putuo District Health System (No. 17-PT-10), Shanghai Municipal Commission of Health and Family Planning Fund (Nos. 20184Y0086, 2016JP007, and 2018JQ003), Project within budget of Shanghai University of Traditional Chinese Medicine (No. 18TS086), the Key Speciality Program (No. 2016102A) and Research Project (No. 2016208A) of Putuo Hospital, Shanghai University of Traditional Chinese Medicine.
The authors confirm that this article content has no conflict of interest.
IntechOpen books are available online by accessing all published content on a chapter level.
",metaTitle:"Access policy",metaDescription:"IntechOpen books are available online by accessing all published content on a chapter level",metaKeywords:null,canonicalURL:null,contentRaw:'[{"type":"htmlEditorComponent","content":"All IntechOpen published chapters are available OPEN ACCESS can be read without the requirement for registration of any kind, immediately upon publication, without any barrier.
\\n\\nThe HTML version, as well as the PDF version of publications dated before 2012 that are accessible through a reader, are available to readers with no restriction.
\\n\\nThe full content of chapters can be read, copied and printed from the link location of the chapter and these actions are not limited or restricted in any way.
\\n\\nRegistration is requested only to download the PDF of the chapter. There are no subscription fees and there is no charge to user groups.
\\n\\nIntechOpen chapters are distributed under CC BY 3.0 licences allowing users to “copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship...” and there is no non-commercial restriction.
\\n\\nAuthors may post published works to any repository or website with no delay, and Authors and Editors of IntechOpen books have direct access to the PDF of the full book.
\\n\\nAll published content can be crawled for indexing. Full text and metadata may be accessed with instructions publicly posted.
\\n\\nAll IntechOpen books are indexed in CLOCKSS and preservation of access to published content is clearly indicated.
\\n\\nPolicy last updated: 2021-02-26
\\n"}]'},components:[{type:"htmlEditorComponent",content:"All IntechOpen published chapters are available OPEN ACCESS can be read without the requirement for registration of any kind, immediately upon publication, without any barrier.
\n\nThe HTML version, as well as the PDF version of publications dated before 2012 that are accessible through a reader, are available to readers with no restriction.
\n\nThe full content of chapters can be read, copied and printed from the link location of the chapter and these actions are not limited or restricted in any way.
\n\nRegistration is requested only to download the PDF of the chapter. There are no subscription fees and there is no charge to user groups.
\n\nIntechOpen chapters are distributed under CC BY 3.0 licences allowing users to “copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship...” and there is no non-commercial restriction.
\n\nAuthors may post published works to any repository or website with no delay, and Authors and Editors of IntechOpen books have direct access to the PDF of the full book.
\n\nAll published content can be crawled for indexing. Full text and metadata may be accessed with instructions publicly posted.
\n\nAll IntechOpen books are indexed in CLOCKSS and preservation of access to published content is clearly indicated.
\n\nPolicy last updated: 2021-02-26
\n"}]},successStories:{items:[]},authorsAndEditors:{filterParams:{sort:"featured,name"},profiles:[{id:"6700",title:"Dr.",name:"Abbass A.",middleName:null,surname:"Hashim",slug:"abbass-a.-hashim",fullName:"Abbass A. Hashim",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/6700/images/1864_n.jpg",biography:"Currently I am carrying out research in several areas of interest, mainly covering work on chemical and bio-sensors, semiconductor thin film device fabrication and characterisation.\nAt the moment I have very strong interest in radiation environmental pollution and bacteriology treatment. The teams of researchers are working very hard to bring novel results in this field. I am also a member of the team in charge for the supervision of Ph.D. students in the fields of development of silicon based planar waveguide sensor devices, study of inelastic electron tunnelling in planar tunnelling nanostructures for sensing applications and development of organotellurium(IV) compounds for semiconductor applications. I am a specialist in data analysis techniques and nanosurface structure. I have served as the editor for many books, been a member of the editorial board in science journals, have published many papers and hold many patents.",institutionString:null,institution:{name:"Sheffield Hallam University",country:{name:"United Kingdom"}}},{id:"54525",title:"Prof.",name:"Abdul Latif",middleName:null,surname:"Ahmad",slug:"abdul-latif-ahmad",fullName:"Abdul Latif Ahmad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"20567",title:"Prof.",name:"Ado",middleName:null,surname:"Jorio",slug:"ado-jorio",fullName:"Ado Jorio",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Federal de Minas Gerais",country:{name:"Brazil"}}},{id:"47940",title:"Dr.",name:"Alberto",middleName:null,surname:"Mantovani",slug:"alberto-mantovani",fullName:"Alberto Mantovani",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"12392",title:"Mr.",name:"Alex",middleName:null,surname:"Lazinica",slug:"alex-lazinica",fullName:"Alex Lazinica",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/12392/images/7282_n.png",biography:"Alex Lazinica is the founder and CEO of IntechOpen. After obtaining a Master's degree in Mechanical Engineering, he continued his PhD studies in Robotics at the Vienna University of Technology. Here he worked as a robotic researcher with the university's Intelligent Manufacturing Systems Group as well as a guest researcher at various European universities, including the Swiss Federal Institute of Technology Lausanne (EPFL). During this time he published more than 20 scientific papers, gave presentations, served as a reviewer for major robotic journals and conferences and most importantly he co-founded and built the International Journal of Advanced Robotic Systems- world's first Open Access journal in the field of robotics. Starting this journal was a pivotal point in his career, since it was a pathway to founding IntechOpen - Open Access publisher focused on addressing academic researchers needs. Alex is a personification of IntechOpen key values being trusted, open and entrepreneurial. Today his focus is on defining the growth and development strategy for the company.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"19816",title:"Prof.",name:"Alexander",middleName:null,surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/19816/images/1607_n.jpg",biography:"Alexander I. Kokorin: born: 1947, Moscow; DSc., PhD; Principal Research Fellow (Research Professor) of Department of Kinetics and Catalysis, N. Semenov Institute of Chemical Physics, Russian Academy of Sciences, Moscow.\r\nArea of research interests: physical chemistry of complex-organized molecular and nanosized systems, including polymer-metal complexes; the surface of doped oxide semiconductors. He is an expert in structural, absorptive, catalytic and photocatalytic properties, in structural organization and dynamic features of ionic liquids, in magnetic interactions between paramagnetic centers. The author or co-author of 3 books, over 200 articles and reviews in scientific journals and books. He is an actual member of the International EPR/ESR Society, European Society on Quantum Solar Energy Conversion, Moscow House of Scientists, of the Board of Moscow Physical Society.",institutionString:null,institution:{name:"Semenov Institute of Chemical Physics",country:{name:"Russia"}}},{id:"62389",title:"PhD.",name:"Ali Demir",middleName:null,surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/62389/images/3413_n.jpg",biography:"Dr. Ali Demir Sezer has a Ph.D. from Pharmaceutical Biotechnology at the Faculty of Pharmacy, University of Marmara (Turkey). He is the member of many Pharmaceutical Associations and acts as a reviewer of scientific journals and European projects under different research areas such as: drug delivery systems, nanotechnology and pharmaceutical biotechnology. Dr. Sezer is the author of many scientific publications in peer-reviewed journals and poster communications. Focus of his research activity is drug delivery, physico-chemical characterization and biological evaluation of biopolymers micro and nanoparticles as modified drug delivery system, and colloidal drug carriers (liposomes, nanoparticles etc.).",institutionString:null,institution:{name:"Marmara University",country:{name:"Turkey"}}},{id:"61051",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"100762",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"St David's Medical Center",country:{name:"United States of America"}}},{id:"107416",title:"Dr.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Texas Cardiac Arrhythmia",country:{name:"United States of America"}}},{id:"64434",title:"Dr.",name:"Angkoon",middleName:null,surname:"Phinyomark",slug:"angkoon-phinyomark",fullName:"Angkoon Phinyomark",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/64434/images/2619_n.jpg",biography:"My name is Angkoon Phinyomark. I received a B.Eng. degree in Computer Engineering with First Class Honors in 2008 from Prince of Songkla University, Songkhla, Thailand, where I received a Ph.D. degree in Electrical Engineering. My research interests are primarily in the area of biomedical signal processing and classification notably EMG (electromyography signal), EOG (electrooculography signal), and EEG (electroencephalography signal), image analysis notably breast cancer analysis and optical coherence tomography, and rehabilitation engineering. I became a student member of IEEE in 2008. During October 2011-March 2012, I had worked at School of Computer Science and Electronic Engineering, University of Essex, Colchester, Essex, United Kingdom. In addition, during a B.Eng. I had been a visiting research student at Faculty of Computer Science, University of Murcia, Murcia, Spain for three months.\n\nI have published over 40 papers during 5 years in refereed journals, books, and conference proceedings in the areas of electro-physiological signals processing and classification, notably EMG and EOG signals, fractal analysis, wavelet analysis, texture analysis, feature extraction and machine learning algorithms, and assistive and rehabilitative devices. I have several computer programming language certificates, i.e. Sun Certified Programmer for the Java 2 Platform 1.4 (SCJP), Microsoft Certified Professional Developer, Web Developer (MCPD), Microsoft Certified Technology Specialist, .NET Framework 2.0 Web (MCTS). I am a Reviewer for several refereed journals and international conferences, such as IEEE Transactions on Biomedical Engineering, IEEE Transactions on Industrial Electronics, Optic Letters, Measurement Science Review, and also a member of the International Advisory Committee for 2012 IEEE Business Engineering and Industrial Applications and 2012 IEEE Symposium on Business, Engineering and Industrial Applications.",institutionString:null,institution:{name:"Joseph Fourier University",country:{name:"France"}}},{id:"55578",title:"Dr.",name:"Antonio",middleName:null,surname:"Jurado-Navas",slug:"antonio-jurado-navas",fullName:"Antonio Jurado-Navas",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/55578/images/4574_n.png",biography:"Antonio Jurado-Navas received the M.S. degree (2002) and the Ph.D. degree (2009) in Telecommunication Engineering, both from the University of Málaga (Spain). He first worked as a consultant at Vodafone-Spain. From 2004 to 2011, he was a Research Assistant with the Communications Engineering Department at the University of Málaga. In 2011, he became an Assistant Professor in the same department. From 2012 to 2015, he was with Ericsson Spain, where he was working on geo-location\ntools for third generation mobile networks. Since 2015, he is a Marie-Curie fellow at the Denmark Technical University. His current research interests include the areas of mobile communication systems and channel modeling in addition to atmospheric optical communications, adaptive optics and statistics",institutionString:null,institution:{name:"University of Malaga",country:{name:"Spain"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:5766},{group:"region",caption:"Middle and South America",value:2,count:5227},{group:"region",caption:"Africa",value:3,count:1717},{group:"region",caption:"Asia",value:4,count:10367},{group:"region",caption:"Australia and Oceania",value:5,count:897},{group:"region",caption:"Europe",value:6,count:15789}],offset:12,limit:12,total:118188},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{sort:"dateEndThirdStepPublish"},books:[{type:"book",id:"10231",title:"Proton Therapy",subtitle:null,isOpenForSubmission:!0,hash:"f4a9009287953c8d1d89f0fa9b7597b0",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10231.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10652",title:"Visual Object Tracking",subtitle:null,isOpenForSubmission:!0,hash:"96f3ee634a7ba49fa195e50475412af4",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10652.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10653",title:"Optimization Algorithms",subtitle:null,isOpenForSubmission:!0,hash:"753812dbb9a6f6b57645431063114f6c",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10653.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10655",title:"Motion Planning",subtitle:null,isOpenForSubmission:!0,hash:"809b5e290cf2dade9e7e0a5ae0ef3df0",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10655.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10657",title:"Service Robots",subtitle:null,isOpenForSubmission:!0,hash:"5f81b9eea6eb3f9af984031b7af35588",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10657.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10662",title:"Pedagogy",subtitle:null,isOpenForSubmission:!0,hash:"c858e1c6fb878d3b895acbacec624576",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10662.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10673",title:"The Psychology of Trust",subtitle:null,isOpenForSubmission:!0,hash:"1f6cac41fd145f718ac0866264499cc8",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10673.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10675",title:"Hydrostatics",subtitle:null,isOpenForSubmission:!0,hash:"c86c2fa9f835d4ad5e7efd8b01921866",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10675.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10677",title:"Topology",subtitle:null,isOpenForSubmission:!0,hash:"85eac84b173d785f989522397616124e",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10677.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10678",title:"Biostatistics",subtitle:null,isOpenForSubmission:!0,hash:"f63db439474a574454a66894db8b394c",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10678.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10679",title:"Mass Production",subtitle:null,isOpenForSubmission:!0,hash:"2dae91102099b1a07be1a36a68852829",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10679.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10684",title:"Biorefineries",subtitle:null,isOpenForSubmission:!0,hash:"23962c6b77348bcbf247c673d34562f6",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10684.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:14},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:3},{group:"topic",caption:"Business, Management and Economics",value:7,count:1},{group:"topic",caption:"Chemistry",value:8,count:7},{group:"topic",caption:"Computer and Information Science",value:9,count:6},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:7},{group:"topic",caption:"Engineering",value:11,count:15},{group:"topic",caption:"Environmental Sciences",value:12,count:2},{group:"topic",caption:"Immunology and Microbiology",value:13,count:3},{group:"topic",caption:"Materials Science",value:14,count:5},{group:"topic",caption:"Mathematics",value:15,count:1},{group:"topic",caption:"Medicine",value:16,count:24},{group:"topic",caption:"Neuroscience",value:18,count:1},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:2},{group:"topic",caption:"Physics",value:20,count:2},{group:"topic",caption:"Psychology",value:21,count:4},{group:"topic",caption:"Social Sciences",value:23,count:2},{group:"topic",caption:"Technology",value:24,count:1},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:1}],offset:12,limit:12,total:187},popularBooks:{featuredBooks:[],offset:0,limit:12,total:null},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9644",title:"Glaciers and the Polar Environment",subtitle:null,isOpenForSubmission:!1,hash:"e8cfdc161794e3753ced54e6ff30873b",slug:"glaciers-and-the-polar-environment",bookSignature:"Masaki Kanao, Danilo Godone and Niccolò Dematteis",coverURL:"https://cdn.intechopen.com/books/images_new/9644.jpg",editors:[{id:"51959",title:"Dr.",name:"Masaki",middleName:null,surname:"Kanao",slug:"masaki-kanao",fullName:"Masaki Kanao"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8985",title:"Natural Resources Management and Biological Sciences",subtitle:null,isOpenForSubmission:!1,hash:"5c2e219a6c021a40b5a20c041dea88c4",slug:"natural-resources-management-and-biological-sciences",bookSignature:"Edward R. Rhodes and Humood Naser",coverURL:"https://cdn.intechopen.com/books/images_new/8985.jpg",editors:[{id:"280886",title:"Prof.",name:"Edward R",middleName:null,surname:"Rhodes",slug:"edward-r-rhodes",fullName:"Edward R Rhodes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9671",title:"Macrophages",subtitle:null,isOpenForSubmission:!1,hash:"03b00fdc5f24b71d1ecdfd75076bfde6",slug:"macrophages",bookSignature:"Hridayesh Prakash",coverURL:"https://cdn.intechopen.com/books/images_new/9671.jpg",editors:[{id:"287184",title:"Dr.",name:"Hridayesh",middleName:null,surname:"Prakash",slug:"hridayesh-prakash",fullName:"Hridayesh Prakash"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9313",title:"Clay Science and Technology",subtitle:null,isOpenForSubmission:!1,hash:"6fa7e70396ff10620e032bb6cfa6fb72",slug:"clay-science-and-technology",bookSignature:"Gustavo Morari Do Nascimento",coverURL:"https://cdn.intechopen.com/books/images_new/9313.jpg",editors:[{id:"7153",title:"Prof.",name:"Gustavo",middleName:null,surname:"Morari Do Nascimento",slug:"gustavo-morari-do-nascimento",fullName:"Gustavo Morari Do Nascimento"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9888",title:"Nuclear Power Plants",subtitle:"The Processes from the Cradle to the Grave",isOpenForSubmission:!1,hash:"c2c8773e586f62155ab8221ebb72a849",slug:"nuclear-power-plants-the-processes-from-the-cradle-to-the-grave",bookSignature:"Nasser Awwad",coverURL:"https://cdn.intechopen.com/books/images_new/9888.jpg",editors:[{id:"145209",title:"Prof.",name:"Nasser",middleName:"S",surname:"Awwad",slug:"nasser-awwad",fullName:"Nasser Awwad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9027",title:"Human Blood Group Systems and Haemoglobinopathies",subtitle:null,isOpenForSubmission:!1,hash:"d00d8e40b11cfb2547d1122866531c7e",slug:"human-blood-group-systems-and-haemoglobinopathies",bookSignature:"Osaro Erhabor and Anjana Munshi",coverURL:"https://cdn.intechopen.com/books/images_new/9027.jpg",editors:[{id:"35140",title:null,name:"Osaro",middleName:null,surname:"Erhabor",slug:"osaro-erhabor",fullName:"Osaro Erhabor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10432",title:"Casting Processes and Modelling of Metallic Materials",subtitle:null,isOpenForSubmission:!1,hash:"2c5c9df938666bf5d1797727db203a6d",slug:"casting-processes-and-modelling-of-metallic-materials",bookSignature:"Zakaria Abdallah and Nada Aldoumani",coverURL:"https://cdn.intechopen.com/books/images_new/10432.jpg",editors:[{id:"201670",title:"Dr.",name:"Zak",middleName:null,surname:"Abdallah",slug:"zak-abdallah",fullName:"Zak Abdallah"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7841",title:"New Insights Into Metabolic Syndrome",subtitle:null,isOpenForSubmission:!1,hash:"ef5accfac9772b9e2c9eff884f085510",slug:"new-insights-into-metabolic-syndrome",bookSignature:"Akikazu Takada",coverURL:"https://cdn.intechopen.com/books/images_new/7841.jpg",editors:[{id:"248459",title:"Dr.",name:"Akikazu",middleName:null,surname:"Takada",slug:"akikazu-takada",fullName:"Akikazu Takada"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"9550",title:"Entrepreneurship",subtitle:"Contemporary Issues",isOpenForSubmission:!1,hash:"9b4ac1ee5b743abf6f88495452b1e5e7",slug:"entrepreneurship-contemporary-issues",bookSignature:"Mladen Turuk",coverURL:"https://cdn.intechopen.com/books/images_new/9550.jpg",editedByType:"Edited by",editors:[{id:"319755",title:"Prof.",name:"Mladen",middleName:null,surname:"Turuk",slug:"mladen-turuk",fullName:"Mladen Turuk"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editedByType:"Edited by",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9313",title:"Clay Science and Technology",subtitle:null,isOpenForSubmission:!1,hash:"6fa7e70396ff10620e032bb6cfa6fb72",slug:"clay-science-and-technology",bookSignature:"Gustavo Morari Do Nascimento",coverURL:"https://cdn.intechopen.com/books/images_new/9313.jpg",editedByType:"Edited by",editors:[{id:"7153",title:"Prof.",name:"Gustavo",middleName:null,surname:"Morari Do Nascimento",slug:"gustavo-morari-do-nascimento",fullName:"Gustavo Morari Do Nascimento"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9888",title:"Nuclear Power Plants",subtitle:"The Processes from the Cradle to the Grave",isOpenForSubmission:!1,hash:"c2c8773e586f62155ab8221ebb72a849",slug:"nuclear-power-plants-the-processes-from-the-cradle-to-the-grave",bookSignature:"Nasser Awwad",coverURL:"https://cdn.intechopen.com/books/images_new/9888.jpg",editedByType:"Edited by",editors:[{id:"145209",title:"Prof.",name:"Nasser",middleName:"S",surname:"Awwad",slug:"nasser-awwad",fullName:"Nasser Awwad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8098",title:"Resources of Water",subtitle:null,isOpenForSubmission:!1,hash:"d251652996624d932ef7b8ed62cf7cfc",slug:"resources-of-water",bookSignature:"Prathna Thanjavur Chandrasekaran, Muhammad Salik Javaid, Aftab Sadiq",coverURL:"https://cdn.intechopen.com/books/images_new/8098.jpg",editedByType:"Edited by",editors:[{id:"167917",title:"Dr.",name:"Prathna",middleName:null,surname:"Thanjavur Chandrasekaran",slug:"prathna-thanjavur-chandrasekaran",fullName:"Prathna Thanjavur Chandrasekaran"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9644",title:"Glaciers and the Polar Environment",subtitle:null,isOpenForSubmission:!1,hash:"e8cfdc161794e3753ced54e6ff30873b",slug:"glaciers-and-the-polar-environment",bookSignature:"Masaki Kanao, Danilo Godone and Niccolò Dematteis",coverURL:"https://cdn.intechopen.com/books/images_new/9644.jpg",editedByType:"Edited by",editors:[{id:"51959",title:"Dr.",name:"Masaki",middleName:null,surname:"Kanao",slug:"masaki-kanao",fullName:"Masaki Kanao"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10432",title:"Casting Processes and Modelling of Metallic Materials",subtitle:null,isOpenForSubmission:!1,hash:"2c5c9df938666bf5d1797727db203a6d",slug:"casting-processes-and-modelling-of-metallic-materials",bookSignature:"Zakaria Abdallah and Nada Aldoumani",coverURL:"https://cdn.intechopen.com/books/images_new/10432.jpg",editedByType:"Edited by",editors:[{id:"201670",title:"Dr.",name:"Zak",middleName:null,surname:"Abdallah",slug:"zak-abdallah",fullName:"Zak Abdallah"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9671",title:"Macrophages",subtitle:null,isOpenForSubmission:!1,hash:"03b00fdc5f24b71d1ecdfd75076bfde6",slug:"macrophages",bookSignature:"Hridayesh Prakash",coverURL:"https://cdn.intechopen.com/books/images_new/9671.jpg",editedByType:"Edited by",editors:[{id:"287184",title:"Dr.",name:"Hridayesh",middleName:null,surname:"Prakash",slug:"hridayesh-prakash",fullName:"Hridayesh Prakash"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8415",title:"Extremophilic Microbes and Metabolites",subtitle:"Diversity, Bioprospecting and Biotechnological Applications",isOpenForSubmission:!1,hash:"93e0321bc93b89ff73730157738f8f97",slug:"extremophilic-microbes-and-metabolites-diversity-bioprospecting-and-biotechnological-applications",bookSignature:"Afef Najjari, Ameur Cherif, Haïtham Sghaier and Hadda Imene Ouzari",coverURL:"https://cdn.intechopen.com/books/images_new/8415.jpg",editedByType:"Edited by",editors:[{id:"196823",title:"Dr.",name:"Afef",middleName:null,surname:"Najjari",slug:"afef-najjari",fullName:"Afef Najjari"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9731",title:"Oxidoreductase",subtitle:null,isOpenForSubmission:!1,hash:"852e6f862c85fc3adecdbaf822e64e6e",slug:"oxidoreductase",bookSignature:"Mahmoud Ahmed Mansour",coverURL:"https://cdn.intechopen.com/books/images_new/9731.jpg",editedByType:"Edited by",editors:[{id:"224662",title:"Prof.",name:"Mahmoud Ahmed",middleName:null,surname:"Mansour",slug:"mahmoud-ahmed-mansour",fullName:"Mahmoud Ahmed Mansour"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"349",title:"Agrobiology",slug:"agrobiology",parent:{title:"Plant Biology",slug:"agricultural-and-biological-sciences-plant-biology"},numberOfBooks:4,numberOfAuthorsAndEditors:109,numberOfWosCitations:100,numberOfCrossrefCitations:46,numberOfDimensionsCitations:149,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicSlug:"agrobiology",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"8954",title:"Biostimulants in Plant Science",subtitle:null,isOpenForSubmission:!1,hash:"ac0eb3328820cca42cb7d6cdbfca4ec2",slug:"biostimulants-in-plant-science",bookSignature:"Seyed Mahyar Mirmajlessi and Ramalingam Radhakrishnan",coverURL:"https://cdn.intechopen.com/books/images_new/8954.jpg",editedByType:"Edited by",editors:[{id:"100573",title:"Dr.",name:"Seyed Mahyar",middleName:null,surname:"Mirmajlessi",slug:"seyed-mahyar-mirmajlessi",fullName:"Seyed Mahyar Mirmajlessi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8004",title:"Nitrogen Fixation",subtitle:null,isOpenForSubmission:!1,hash:"02f39c8365ba155d1c520184c2f26976",slug:"nitrogen-fixation",bookSignature:"Everlon Cid Rigobelo and Ademar Pereira Serra",coverURL:"https://cdn.intechopen.com/books/images_new/8004.jpg",editedByType:"Edited by",editors:[{id:"39553",title:"Prof.",name:"Everlon",middleName:"Cid",surname:"Rigobelo",slug:"everlon-rigobelo",fullName:"Everlon Rigobelo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7206",title:"Corn",subtitle:"Production and Human Health in Changing Climate",isOpenForSubmission:!1,hash:"0140cb7a425a230a388fcece870e62b2",slug:"corn-production-and-human-health-in-changing-climate",bookSignature:"Amanullah and Shah Fahad",coverURL:"https://cdn.intechopen.com/books/images_new/7206.jpg",editedByType:"Edited by",editors:[{id:"178825",title:"Dr.",name:"Dr.",middleName:null,surname:"Amanullah",slug:"dr.-amanullah",fullName:"Dr. Amanullah"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1958",title:"Phytochemicals as Nutraceuticals",subtitle:"Global Approaches to Their Role in Nutrition and Health",isOpenForSubmission:!1,hash:"7a4d422838dabdc758119a7dfc6e7a54",slug:"phytochemicals-as-nutraceuticals-global-approaches-to-their-role-in-nutrition-and-health",bookSignature:"Venketeshwer Rao",coverURL:"https://cdn.intechopen.com/books/images_new/1958.jpg",editedByType:"Edited by",editors:[{id:"82663",title:"Dr.",name:"Venketeshwer",middleName:null,surname:"Rao",slug:"venketeshwer-rao",fullName:"Venketeshwer Rao"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:4,mostCitedChapters:[{id:"32893",doi:"10.5772/26956",title:"Biological Oxidations and Antioxidant Activity of Natural Products",slug:"biological-oxidations-and-antioxidant-activity-of-natural-products",totalDownloads:5558,totalCrossrefCites:4,totalDimensionsCites:24,book:{slug:"phytochemicals-as-nutraceuticals-global-approaches-to-their-role-in-nutrition-and-health",title:"Phytochemicals as Nutraceuticals",fullTitle:"Phytochemicals as Nutraceuticals - Global Approaches to Their Role in Nutrition and Health"},signatures:"Xirley Pereira Nunes, Fabrício Souza Silva, Jackson Roberto Guedes da S. Almeida, Julianeli Tolentino de Lima, Luciano Augusto de Araújo Ribeiro, Lucindo José Quintans Júnior and José Maria Barbosa Filho",authors:[{id:"68388",title:"Dr.",name:"Xirley",middleName:null,surname:"Nunes",slug:"xirley-nunes",fullName:"Xirley Nunes"},{id:"70159",title:"Dr.",name:"Lucindo",middleName:null,surname:"Quintans-Júnior",slug:"lucindo-quintans-junior",fullName:"Lucindo Quintans-Júnior"},{id:"72113",title:"Prof.",name:"Jackson",middleName:"Roberto Guedes Da Silva",surname:"Almeida",slug:"jackson-almeida",fullName:"Jackson Almeida"},{id:"72114",title:"Dr.",name:"Julianeli",middleName:"Tolentino",surname:"Lima",slug:"julianeli-lima",fullName:"Julianeli Lima"},{id:"73341",title:"Prof.",name:"José Maria",middleName:null,surname:"Barbosa-Filho",slug:"jose-maria-barbosa-filho",fullName:"José Maria Barbosa-Filho"},{id:"76185",title:"Dr.",name:"Luciano",middleName:null,surname:"Ribeiro",slug:"luciano-ribeiro",fullName:"Luciano Ribeiro"},{id:"76187",title:"MSc.",name:"Fabrício",middleName:null,surname:"Silva",slug:"fabricio-silva",fullName:"Fabrício Silva"}]},{id:"32901",doi:"10.5772/27843",title:"Plant Polyphenols as Antioxidants Influencing the Human Health",slug:"plant-polyphenols-as-antioxidants-influencing-the-human-health",totalDownloads:6327,totalCrossrefCites:7,totalDimensionsCites:22,book:{slug:"phytochemicals-as-nutraceuticals-global-approaches-to-their-role-in-nutrition-and-health",title:"Phytochemicals as Nutraceuticals",fullTitle:"Phytochemicals as Nutraceuticals - Global Approaches to Their Role in Nutrition and Health"},signatures:"Sanda Vladimir-Knežević, Biljana Blažeković, Maja Bival Štefan and Marija Babac",authors:[{id:"71793",title:"Dr.",name:"Biljana",middleName:null,surname:"Blazekovic",slug:"biljana-blazekovic",fullName:"Biljana Blazekovic"},{id:"76049",title:"Prof.",name:"Sanda",middleName:null,surname:"Vladimir-Knežević",slug:"sanda-vladimir-knezevic",fullName:"Sanda Vladimir-Knežević"},{id:"76050",title:"MSc.",name:"Maja",middleName:null,surname:"Bival Štefan",slug:"maja-bival-stefan",fullName:"Maja Bival Štefan"},{id:"76054",title:"MSc.",name:"Marija",middleName:null,surname:"Babac",slug:"marija-babac",fullName:"Marija Babac"}]},{id:"32903",doi:"10.5772/30459",title:"Potato Peel as a Source of Important Phytochemical Antioxidant Nutraceuticals and Their Role in Human Health - A Review",slug:"potato-peel-as-a-source-of-important-phytochemical-antioxidant-nutraceuticals-and-their-role-in-huma",totalDownloads:8012,totalCrossrefCites:8,totalDimensionsCites:18,book:{slug:"phytochemicals-as-nutraceuticals-global-approaches-to-their-role-in-nutrition-and-health",title:"Phytochemicals as Nutraceuticals",fullTitle:"Phytochemicals as Nutraceuticals - Global Approaches to Their Role in Nutrition and Health"},signatures:"A. Al-Weshahy and V.A. Rao",authors:[{id:"82663",title:"Dr.",name:"Venketeshwer",middleName:null,surname:"Rao",slug:"venketeshwer-rao",fullName:"Venketeshwer Rao"},{id:"150485",title:"Dr.",name:"Amir",middleName:null,surname:"Al-Weshahy",slug:"amir-al-weshahy",fullName:"Amir Al-Weshahy"}]}],mostDownloadedChaptersLast30Days:[{id:"69956",title:"Biostimulants and Their Role in Improving Plant Growth under Abiotic Stresses",slug:"biostimulants-and-their-role-in-improving-plant-growth-under-abiotic-stresses",totalDownloads:1161,totalCrossrefCites:2,totalDimensionsCites:4,book:{slug:"biostimulants-in-plant-science",title:"Biostimulants in Plant Science",fullTitle:"Biostimulants in Plant Science"},signatures:"Ana Carolina Feitosa de Vasconcelos and Lúcia Helena Garófalo Chaves",authors:null},{id:"67454",title:"Nitrogen Fertilization I: Impact on Crop, Soil, and Environment",slug:"nitrogen-fertilization-i-impact-on-crop-soil-and-environment",totalDownloads:535,totalCrossrefCites:1,totalDimensionsCites:2,book:{slug:"nitrogen-fixation",title:"Nitrogen Fixation",fullTitle:"Nitrogen Fixation"},signatures:"Upendra M. Sainju, Rajan Ghimire and Gautam P. Pradhan",authors:[{id:"214367",title:"Dr.",name:"Upendra",middleName:null,surname:"Sainju",slug:"upendra-sainju",fullName:"Upendra Sainju"},{id:"266570",title:"Prof.",name:"Rajan",middleName:null,surname:"Ghimire",slug:"rajan-ghimire",fullName:"Rajan Ghimire"},{id:"266571",title:"Prof.",name:"Gautam",middleName:null,surname:"Pradhan",slug:"gautam-pradhan",fullName:"Gautam Pradhan"}]},{id:"69577",title:"Role of Fungi in Agriculture",slug:"role-of-fungi-in-agriculture",totalDownloads:561,totalCrossrefCites:0,totalDimensionsCites:1,book:{slug:"biostimulants-in-plant-science",title:"Biostimulants in Plant Science",fullTitle:"Biostimulants in Plant Science"},signatures:"Muthuraman Yuvaraj and Murugaragavan Ramasamy",authors:null},{id:"70950",title:"Role of Biofertilizers in Plant Growth and Soil Health",slug:"role-of-biofertilizers-in-plant-growth-and-soil-health",totalDownloads:559,totalCrossrefCites:1,totalDimensionsCites:1,book:{slug:"nitrogen-fixation",title:"Nitrogen Fixation",fullTitle:"Nitrogen Fixation"},signatures:"Murugaragavan Ramasamy, T. Geetha and M. Yuvaraj",authors:[{id:"289410",title:"Dr.",name:"Murugaragavan",middleName:null,surname:"Ramasamy",slug:"murugaragavan-ramasamy",fullName:"Murugaragavan Ramasamy"}]},{id:"62653",title:"Phytochemical Composition: Antioxidant Potential and Biological Activities of Corn",slug:"phytochemical-composition-antioxidant-potential-and-biological-activities-of-corn",totalDownloads:1440,totalCrossrefCites:0,totalDimensionsCites:2,book:{slug:"corn-production-and-human-health-in-changing-climate",title:"Corn",fullTitle:"Corn - Production and Human Health in Changing Climate"},signatures:"Haq Nawaz, Saima Muzaffar, Momna Aslam and Shakeel Ahmad",authors:[{id:"230900",title:"Mr.",name:"Haq",middleName:null,surname:"Nawaz",slug:"haq-nawaz",fullName:"Haq Nawaz"},{id:"244066",title:"Prof.",name:"Saima",middleName:null,surname:"Muzaffar",slug:"saima-muzaffar",fullName:"Saima Muzaffar"},{id:"263041",title:"Ms.",name:"Momna",middleName:null,surname:"Aslam",slug:"momna-aslam",fullName:"Momna Aslam"},{id:"263042",title:"Dr.",name:"Shakeel",middleName:null,surname:"Ahmad",slug:"shakeel-ahmad",fullName:"Shakeel Ahmad"}]},{id:"32893",title:"Biological Oxidations and Antioxidant Activity of Natural Products",slug:"biological-oxidations-and-antioxidant-activity-of-natural-products",totalDownloads:5555,totalCrossrefCites:4,totalDimensionsCites:23,book:{slug:"phytochemicals-as-nutraceuticals-global-approaches-to-their-role-in-nutrition-and-health",title:"Phytochemicals as Nutraceuticals",fullTitle:"Phytochemicals as Nutraceuticals - Global Approaches to Their Role in Nutrition and Health"},signatures:"Xirley Pereira Nunes, Fabrício Souza Silva, Jackson Roberto Guedes da S. Almeida, Julianeli Tolentino de Lima, Luciano Augusto de Araújo Ribeiro, Lucindo José Quintans Júnior and José Maria Barbosa Filho",authors:[{id:"68388",title:"Dr.",name:"Xirley",middleName:null,surname:"Nunes",slug:"xirley-nunes",fullName:"Xirley Nunes"},{id:"70159",title:"Dr.",name:"Lucindo",middleName:null,surname:"Quintans-Júnior",slug:"lucindo-quintans-junior",fullName:"Lucindo Quintans-Júnior"},{id:"72113",title:"Prof.",name:"Jackson",middleName:"Roberto Guedes Da Silva",surname:"Almeida",slug:"jackson-almeida",fullName:"Jackson Almeida"},{id:"72114",title:"Dr.",name:"Julianeli",middleName:"Tolentino",surname:"Lima",slug:"julianeli-lima",fullName:"Julianeli Lima"},{id:"73341",title:"Prof.",name:"José Maria",middleName:null,surname:"Barbosa-Filho",slug:"jose-maria-barbosa-filho",fullName:"José Maria Barbosa-Filho"},{id:"76185",title:"Dr.",name:"Luciano",middleName:null,surname:"Ribeiro",slug:"luciano-ribeiro",fullName:"Luciano Ribeiro"},{id:"76187",title:"MSc.",name:"Fabrício",middleName:null,surname:"Silva",slug:"fabricio-silva",fullName:"Fabrício Silva"}]},{id:"61112",title:"Climate Change Impacts on Corn Phenology and Productivity",slug:"climate-change-impacts-on-corn-phenology-and-productivity",totalDownloads:920,totalCrossrefCites:6,totalDimensionsCites:6,book:{slug:"corn-production-and-human-health-in-changing-climate",title:"Corn",fullTitle:"Corn - Production and Human Health in Changing Climate"},signatures:"Jerry L. Hatfield and Christian Dold",authors:[{id:"29632",title:"Dr.",name:"Jerry",middleName:null,surname:"Hatfield",slug:"jerry-hatfield",fullName:"Jerry Hatfield"},{id:"244478",title:"Dr.",name:"Christian",middleName:null,surname:"Dold",slug:"christian-dold",fullName:"Christian Dold"}]},{id:"69645",title:"Applications and Constraints of Plant Beneficial Microorganisms in Agriculture",slug:"applications-and-constraints-of-plant-beneficial-microorganisms-in-agriculture",totalDownloads:624,totalCrossrefCites:0,totalDimensionsCites:3,book:{slug:"biostimulants-in-plant-science",title:"Biostimulants in Plant Science",fullTitle:"Biostimulants in Plant Science"},signatures:"Sovan Debnath, Deepa Rawat, Aritra Kumar Mukherjee, Samrat Adhikary and Ritesh Kundu",authors:null},{id:"61809",title:"Corn Productivity: The Role of Management and Biotechnology",slug:"corn-productivity-the-role-of-management-and-biotechnology",totalDownloads:700,totalCrossrefCites:1,totalDimensionsCites:1,book:{slug:"corn-production-and-human-health-in-changing-climate",title:"Corn",fullTitle:"Corn - Production and Human Health in Changing Climate"},signatures:"Jean-Paul Chavas and Paul D. Mitchell",authors:[{id:"245726",title:"Prof.",name:"Jean-Paul",middleName:null,surname:"Chavas",slug:"jean-paul-chavas",fullName:"Jean-Paul Chavas"},{id:"253451",title:"Dr.",name:"Paul D.",middleName:null,surname:"Mitchell",slug:"paul-d.-mitchell",fullName:"Paul D. Mitchell"}]},{id:"67458",title:"Nitrogen Fertilization II: Management Practices to Sustain Crop Production and Soil and Environmental Quality",slug:"nitrogen-fertilization-ii-management-practices-to-sustain-crop-production-and-soil-and-environmental",totalDownloads:340,totalCrossrefCites:0,totalDimensionsCites:1,book:{slug:"nitrogen-fixation",title:"Nitrogen Fixation",fullTitle:"Nitrogen Fixation"},signatures:"Upendra M. Sainju, Rajan Ghimire and Gautam P. Pradhan",authors:[{id:"214367",title:"Dr.",name:"Upendra",middleName:null,surname:"Sainju",slug:"upendra-sainju",fullName:"Upendra Sainju"},{id:"266570",title:"Prof.",name:"Rajan",middleName:null,surname:"Ghimire",slug:"rajan-ghimire",fullName:"Rajan Ghimire"},{id:"266571",title:"Prof.",name:"Gautam",middleName:null,surname:"Pradhan",slug:"gautam-pradhan",fullName:"Gautam Pradhan"}]}],onlineFirstChaptersFilter:{topicSlug:"agrobiology",limit:3,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[{type:"book",id:"10176",title:"Microgrids and Local Energy Systems",subtitle:null,isOpenForSubmission:!0,hash:"c32b4a5351a88f263074b0d0ca813a9c",slug:null,bookSignature:"Prof. Nick Jenkins",coverURL:"https://cdn.intechopen.com/books/images_new/10176.jpg",editedByType:null,editors:[{id:"55219",title:"Prof.",name:"Nick",middleName:null,surname:"Jenkins",slug:"nick-jenkins",fullName:"Nick Jenkins"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:8,limit:8,total:1},route:{name:"profile.detail",path:"/profiles/311550/stefan-bjoerkman",hash:"",query:{},params:{id:"311550",slug:"stefan-bjoerkman"},fullPath:"/profiles/311550/stefan-bjoerkman",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()